Lausanne University Hospital (CHUV) and 10x Genomics have established a new research partnership to develop single-cell and spatial technologies for cancer diagnosis.
With 100 successful treatments completed within 100 days of FDA certification, the Synergy Disc has achieved a noteworthy milestone in the US.
NeuroSense has announced encouraging results from its Phase 2 RoAD proof-of-concept study, revealing positive biomarker findings for PrimeC
Kihealth has announced the launch of Beta Intercept™, a new platform designed to help individuals identify risks earlier
HYPE ETFs have captured the attention of Wall Street after attracting approximately $161 million in inflows within a single month. The strong investment...
Excepteur sint occaecat cupidatat non proident